Binding of Cryptococcus neoformans to heterologously expressed human complement receptors

Infection and Immunity

Volumn 65, Issue 3, 1997, Pages 931-935

  Levitz, Stuart M ^a   Tabuni, Abdulmoneim ^a   Kozel, Thomas R ^b   MacGill, Randall S ^b   Ingalls, Robin R ^a   Golenbock, Douglas T ^a  

^a BOSTON MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT RECEPTOR;

ANTIMICROBIAL ACTIVITY; ARTICLE; BINDING AFFINITY; CHO CELL; COMPLEMENT ACTIVATION; CRYPTOCOCCUS NEOFORMANS; MACROPHAGE FUNCTION; PHAGOCYTOSIS; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR OCCUPANCY;

EID: 0031033519     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.3.931-935.1997     Document Type: Article

References (32)

1. Bilsland, C. A., M. S. Diamond, and T. A. Springer. 1994. The leukocyte integrin p150,95 (CD11c/CD18) as a receptor for iC3b. Activation by a heterologous beta subunit and localization of a ligand recognition site to the I domain. J. Immunol. 152:4582-4589.
2. Brown, E. J., J. F. Bohnsack, and H. D. Gresham. 1988. Mechanism of inhibition of immunoglobulin G-mediated phagocytosis by monoclonal antibodies that recognize the Mac-1 antigen. J. Clin. Invest. 81:365-375.
3. Diamond, M. S., J. Garcia-Aguilar, J. K. Bickford, A. L. Corbi, and T. A. Springer. 1993. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J. Cell Biol. 120:1031-1043.
4. Diamond, R. D. 1995. Cryptococcus neoformans, p. 2331-2340. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas and Bennett's principles and practice of infectious diseases, 4th ed. Churchill Livingstone Inc., New York, N.Y.
5. Fraker, P. J., and J. C. Speck, Jr. 1978. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3.4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80:849-857.
6. Golenbock, D. T., Y. Liu, F. H. Millham, M. W. Freeman, and R. A. Zoeller. 1993. Surface expression of human CD14 in Chinese hamster ovary fibroblasts imparts macrophage-like responsiveness to bacterial endotoxin. J. Biol. Chem. 268:22055-22059.
7. Graham, I. L., H. D. Gresham, and E. J. Brown. 1989. An immobile subset of plasma membrane CD11b/CD18 (Mac-1) is involved in phagocytosis of targets recognized by multiple receptors. J. Immunol. 142:2352-2358.
8. Hermanowski-Vosatka, A., P. A. Detmers, O. Götze, S. C. Silverstein, and S. D. Wright. 1988. Clustering of ligand on the surface of a particle enhances adhesion to receptor-bearing cells. J. Biol. Chem. 263:17822-17827.
9. Horstmann, R. D., M. K. Pangburn, and H. J. Muller-Eberhard. 1985. Species specificity of recognition by the alternative pathway of complement. J. Immunol. 134:1101-1104.
10. Ingalls, R. R., and D. T. Golenbock, 1995. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide. J. Exp. Med. 181:1473-1480.
11. Kozel, T. R. 1983. Dissociation of a hydrophobic surface from phagocytosis of encapsulated and nonencapsulated Cryptococcus neoformans. Infect. Immun. 39:1214-1219.
12. Kozel, T. R., and E. C. Gotschlich. 1982. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J. Immunol. 129:1675-1680.
13. Kozel, T. R., B. Highison, and C. J. Stratton. 1984. Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils. Infect. Immun. 43:574-579.
14. Kozel, T. R., and G. S. T. Pfrommer. 1986. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast. Infect. Immun. 52:1-5.
15. Kozel, T. R., M. A. Wilson, G. S. T. Pfrommer, and A. M. Schlageter. 1989. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconsti tuted from six isolated proteins. Infect. Immun. 57:1922-1927.
16. Levitz, S. M. 1991. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev. Infect. Dis. 13:1163-1169.
17. Levitz, S. M. 1994. Macrophage-Cryptococcus interactions, p. 533-543. In B. S. Zwilling and T. K. Eisenstein (ed.), Macrophage-pathogen interactions. Marcel Dekker. New York, N.Y.
18. Levitz, S. M., and M. P. Dupont. 1993. Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neofonnans in vitro. J. Clin. Invest. 91:1490-1498.
19. Levitz, S. M., and A. Tabuni. 1991. Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin. J. Clin. Invest. 87:528-535.
20. Levitz, S. M., A. Tabuni, S.-H. Nong, and D. T. Golenbock. 1996. Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide. Infect. Immun. 64:945-951.
21. Makrides, S. C., S. M. Scesney, P. J. Ford, K. S. Evans, G. R. Carson, and H. C. Marsh, Jr. 1992. Cell surface expression of the C3b/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement. J. Biol. Chem. 267:24754-24761
22. Myones, B. L., J. G. Dalzell, N. Hogg, and G. D. Ross. 1988. Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. J. Clin. Invest. 82:640-651.
23. Payne, N. R., and M. A. Horwitz. 1987. Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors. J. Exp. Med. 166:1377-1389.
24. Pfrommer, G. S., S. M. Dickens, M. A. Wilson, B. J. Young, and T. R. Kozel. 1993. Accelerated decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans capsule. Infect. Immun. 61:4360-4366.
25. Rabb, H., M. Michishita, C. P. Sharma, D. Brown, and M. A. Arnaout. 1993. Cytoplasmic tails of human complement receptor type 3 (CR3, CD11b/ CD18) regulate ligand avidity and the internalization of occupied receptors. J. Immunol. 151:990-1002.
26. Reilly, B. D., S. C. Makrides, P. J. Ford, H. C. Marsh, Jr., and C. Mold. 1994. Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1). J. Biol. Chem. 269:7696-7701.
27. Ross, G. D., W. Reed, J. G. Dalzell, S. E. Becker, and N. Hogg. 1992. Macrophage cytoskeleton association with CR3 and CR4 regulates receptor mobility and phagocytosis of iC3b-opsonized erythrocytes. J. Leukocyte Biol. 51:109-117.
28. Roubey, R. A., G. D. Ross, J. T. Merrill, F. Walton, W. Reed, R. J. Winchester, and J. P. Buyon. 1991. Staurosporine inhibits neutrophil phagocytosis but not iC3b binding mediated by CR3 (CD11b/CD18). J. Immunol. 146: 3557-3562.
29. Schlesinger, L. S., C. G. Bellinger-Kawahara, N. R. Payne, and M. A. Horwitz. 1990. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J. Immunol. 144:2771-2780.
30. Schlesinger, L. S., and M. A. Horwitz. 1991. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium. J. Immunol. 147:1983-1994.
31. Wright, S. D., L. S. Craigmyle, and S. C. Silverstein. 1983. Fibronectin and serum amyloid P component stimulate C3b- and C3bi-mediated phagocytosis in cultured human monocytes. J. Exp. Med. 158:1338-1343.
32. Wright, S. D., and S. C. Silverstein. 1982. Tumor-promoting phorbol esters stimulate C3b and C3b′ receptor-mediated phagocytosis in cultured human monocytes. J. Exp. Med. 156:1149-1164.